Vitalist Inc. (TSXV:VITA)
Canada · Delayed Price · Currency is CAD 0.6000
-0.1300 (-17.81%)
Jul 31, 2026, 1:40 PM EST
Vitalist Income Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 4.06 | 4.75 | 1.93 | 7.57 | 7.3 | |
Revenue Growth | -14.52% | 145.90% | -74.46% | 3.68% | -21.29% |
Cost of Revenue | 3.92 | 3.42 | 1.65 | 15.66 | 7.07 |
Gross Profit | 0.14 | 1.33 | 0.28 | -8.09 | 0.22 |
Selling, General & Admin | 4.11 | 2.86 | 4.5 | 7.48 | 7.51 |
Research & Development | 0.19 | 0.19 | 0.18 | 0.55 | 0.49 |
Operating Expenses | 4.52 | 3.34 | 4.65 | 8.25 | 9.18 |
Operating Income | -4.37 | -2.01 | -4.37 | -16.35 | -8.96 |
Interest Expense | -1.83 | -1.38 | -1.82 | -2.36 | -1.73 |
Currency Exchange Gain (Loss) | -0.13 | -0.07 | -0.4 | 0.49 | -0.13 |
Other Non Operating Income (Expenses) | -0.36 | -0.12 | -0.24 | -0.08 | 1.98 |
EBT Excluding Unusual Items | -6.69 | -3.58 | -6.83 | -18.29 | -8.84 |
Impairment of Goodwill | - | - | - | -9.81 | - |
Gain (Loss) on Sale of Assets | - | - | 10.62 | - | - |
Asset Writedown | - | - | - | -0.05 | - |
Other Unusual Items | 2.16 | - | 0.38 | -0.03 | -1.42 |
Pretax Income | -4.53 | -3.58 | 4.17 | -28.19 | -10.25 |
Income Tax Expense | - | - | - | -0.12 | -0.04 |
Net Income | -4.53 | -3.58 | 4.17 | -28.07 | -10.22 |
Net Income to Common | -4.53 | -3.58 | 4.17 | -28.07 | -10.22 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 50 | 45 | 21 | 3 | 2 |
Shares Outstanding (Diluted) | 50 | 45 | 21 | 3 | 2 |
Shares Change | 12.19% | 118.02% | 711.47% | 11.46% | 37.47% |
EPS (Basic) | -0.09 | -0.08 | 0.20 | -11.10 | -4.50 |
EPS (Diluted) | -0.09 | -0.08 | 0.20 | -11.10 | -4.50 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -2.33 | -1.51 | -3.71 | -7.28 | -13.04 |
Free Cash Flow Per Share | -0.05 | -0.03 | -0.18 | -2.88 | -5.75 |
Gross Margin | 3.52% | 28.05% | 14.48% | -106.96% | 3.07% |
Operating Margin | -107.66% | -42.32% | -226.03% | -216.06% | -122.80% |
Profit Margin | -111.53% | -75.39% | 215.89% | -371.08% | -140.03% |
Free Cash Flow Margin | -57.36% | -31.72% | -192.22% | -96.27% | -178.64% |
EBITDA | - | - | -4.22 | -16.19 | -7.98 |
EBITDA Margin | - | - | -218.22% | -214.06% | -109.37% |
D&A For EBITDA | - | - | 0.15 | 0.15 | 0.98 |
EBIT | -4.37 | -2.01 | -4.37 | -16.35 | -8.96 |
EBIT Margin | -107.66% | -42.32% | -226.03% | -216.06% | -122.80% |